FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

109053000: Octreotide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173588012 Octreotide en Synonym Active Entire term case insensitive SNOMED CT core module
607669011 Octreotide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Octreotide Is a Somatostatin false Inferred relationship Existential restriction modifier
Octreotide Is a Allergen class false Inferred relationship Existential restriction modifier
Octreotide Is a Drug allergen false Inferred relationship Existential restriction modifier
Octreotide Is a Somatostatin analog true Inferred relationship Existential restriction modifier
Octreotide Is a Cyclic peptide true Inferred relationship Existential restriction modifier
Octreotide Has disposition Hypothalamic inhibiting factor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Octreotide acetate Is a False Octreotide Inferred relationship Existential restriction modifier
Octreotide adverse reaction Causative agent True Octreotide Inferred relationship Existential restriction modifier 1
Product containing octreotide Has active ingredient True Octreotide Inferred relationship Existential restriction modifier 1
Allergy to octreotide Causative agent False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/mL injection solution 1mL ampule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 200micrograms/mL injection solution 5mL vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for injection suspension vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for injection suspension vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for injection suspension vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/mL injection solution ampule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Single photon emission computed tomography using radiolabeled octreotide Using substance False Octreotide Inferred relationship Existential restriction modifier 1
Single photon emission computed tomography using radiolabeled octreotide Using substance False Octreotide Inferred relationship Existential restriction modifier 1
Allergy to octreotide Causative agent True Octreotide Inferred relationship Existential restriction modifier 1
Radiolabeled octreotide Is a False Octreotide Inferred relationship Existential restriction modifier
Indium (111-In) labeled octreotide Is modification of True Octreotide Inferred relationship Existential restriction modifier
Octreotide acetate Is modification of True Octreotide Inferred relationship Existential restriction modifier
Product containing precisely octreotide (as octreotide acetate) 10 milligram/1 vial powder for conventional release suspension for injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule Has basis of strength substance False Octreotide Inferred relationship Existential restriction modifier 1
Product containing octreotide in parenteral dose form (medicinal product form) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier 1
Octreotide Has active ingredient True Octreotide Inferred relationship Existential restriction modifier 1
Product containing only octreotide in parenteral dose form (medicinal product form) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 200 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Octreotide Inferred relationship Existential restriction modifier 1
Radiolabeled octreotide Is modification of True Octreotide Inferred relationship Existential restriction modifier
Single photon emission computed tomography with computed tomography using radiolabelled octreotide Using substance False Octreotide Inferred relationship Existential restriction modifier 1
Octreotide 50micrograms/1mL injection - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1mL injection - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1mL injection - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5mL injection - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg depot injection+solvent - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg depot injection+solvent - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg depot injection+solvent - product Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1mL injection Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1mL injection Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1mL injection Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 1mg/5mL injection Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg depot injection+solvent Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg depot injection+solvent Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg depot injection+solvent Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Olatuton 30mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Olatuton 10mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Olatuton 20mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Olatuton 10mg powder and solvent for prolonged-release suspension for injection vials (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Seacross Pharmaceuticals Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection vials (Seacross Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Medihealth (Northern) Ltd) 5 pre-filled disposable injection Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection pre-filled syringes (Medihealth (Northern) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 100micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 500micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 10mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 20mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 30mg powder and solvent for suspension for injection vials 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 10mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 20mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin LAR 30mg powder and solvent for suspension for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (PI) (Dowelhurst Ltd) 5 ampoule 5 x 1ml ampoules Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 1mg/5ml solution for injection vials (Waymade Ltd) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 1mg/5ml solution for injection vials (Mayne Pharma Plc) 1 vial Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 100micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has active ingredient False Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules 5 ampoule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/1ml solution for injection ampoules (Sun Pharmaceuticals UK Ltd) 5 ampoule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier
Octreotide 50micrograms/mL injection solution 1mL ampule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Octreotide Inferred relationship Existential restriction modifier
Sandostatin 50micrograms/1ml solution for injection ampoules (Waymade Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Octreotide Inferred relationship Existential restriction modifier

Page 1 of 4 Next End

This concept is not in any reference sets

Back to Start